Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      SpaceX snaps up AI coding darling Cursor as valuation soars past Amazon

      Elon Musk speaking at a tech conference, wearing a suit, with a futuristic backdrop highlighting space exploration themes

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Brits urged to back UK pubs during World Cup amid booking surge

      Getty Images logo on a smartphone screen against a blurred background, representing media and stock photo industry branding.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Old Pulteney releases 50-year-old whisky for 200th anniversary

      Old Pulteney 50-Year-Old single malt Scotch whisky bottle with elegant packaging on display, highlighting luxury and craft...

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper

Astrazeneca

  • EU vs Astrazeneca: Vaccine legal battle over as UK pharma pledges jab deliveries

    September 3, 2021

    The legal stand-off between the European Union (EU) and FTSE-listed Covid-19 vaccine maker Astrazeneca appears to be over. Astrazeneca and the European Commission have reached a settlement on the delivery of 200m vaccine doses still to be delivered by the drug com[any, ending a row about shortages that had heightened reputational damage on Astra and weighed [...]

  • Fatal blood clot: Coroner rules AstraZeneca vaccine caused death of BBC host Lisa Shaw

    August 27, 2021

    The death of award-winning BBC radio presenter Lisa Shaw was caused by complications as a result of the AstraZeneca Covid-19 vaccine, a coroner in Newcastle has concluded. Shaw died in May, just over three weeks after she had her first dose of the jab, an inquest in Newcastle heard on Thursday. The 44-year-old – who [...]

  • Astrazeneca’s non-vaccine therapy cuts chance of getting symptomatic Covid by 77 per cent, trial finds

    August 20, 2021

    FTSE-listed Astrazeneca this morning said its Covid-19 antibody therapy met the main goal of preventing coronavirus symptoms in a late-stage study. It means the Anglo-Swedish pharma is on track to potentially offer an alternative to vaccines for people with weakened immune systems. Astrazeneca said it will now submit data to try and get emergency authorisation [...]

  • Who’s Who: Top ten earning FTSE 100 CEOs take home £89.5m

    August 19, 2021

    A new report has revealed that the top ten earning FTSE 100 CEOs took home £89.5m between them in 2020. Pascal Soriot, the chief executive of AstraZeneca, topped the list taking home a healthy paycheck of £15.45m. The report, published by the High Pay Centre, noted that Soriot’s earnings were well above the average pay [...]

  • Barbie doll created of Oxford Covid vaccine designer Dame Sarah Gilbert

    August 4, 2021

    Barbie maker Mattel has created a doll in honour of Professor Dame Sarah Gilbert, the scientist who designed the Oxford-Astrazeneca Covid vaccine. After a standing ovation at Wimbledon and being made a dame, Gilbert now has the Barbie doll to recognise her efforts in creating a life-saving jab. The vaccinologist said she initially found the [...]

  • Sage advisers: Protection given from Covid vaccine ‘highly likely’ to wane over time

    July 30, 2021

    Vaccine campaigns will likely have to continue for many years as the Covid immunity induced by the shots is ‘highly likely to wane over time’, according to scientific advisers to the government. “It is highly likely that vaccine induced immunity to SARS-CoV-2 infection, and potentiallysevere disease (but probably to a lesser extent) will wane over [...]

  • Astrazeneca mulls offloading Covid vaccines unit even as total revenues soar above $15bn

    July 29, 2021

    UK-listed Covid vaccine maker Astrazeneca today admitted it’s considering offloading its vaccines unit even as it cheered a 23 per cent revenue rise to $15.5bn for the first half of 2021 – boosted in part by orders for the preventative measure. A senior executive confirmed to Reuters that it is reviewing the future of the [...]

  • CMA green light: £28bn AstraZeneca and Alexion deal to close late July

    July 14, 2021

    The UK competition watchdog has cleared vaccine maker AstraZeneca’s £28bn bid for rival Alexion, which has been confirmed to close on 21 July. First announced in December last year, the deal is intended to bolster AstraZeneca’s immunology capabilities by adding Alexion’s technology platforms. European Union regulators gave the deal the green light last week. Despite [...]

  • EU regulators clear Astrazeneca’s £28bn takeover of rival Alexion

    July 6, 2021

    European regulators have cleared Astrazeneca’s £28bn takeover of rival Alexion Pharmaceuticals, the British company announced today. The deal, first agreed in December, will give Astrazeneca access to five new drugs and more than a dozen in Alexion’s pipeline. Astra said the clearance from Brussels was an important step towards completed its buyout of the New [...]

  • Pfizer and Moderna vaccine supply limits pace of jab rollout

    June 30, 2021

    There are not enough Pfizer and Moderna vaccines being supplied to reduce the eight week interval between doses, according to analysts. “It appears from the data available that Pfizer and Moderna supplies are the pace-limiting factor,” Matt Linley, an analyst at Airfinity, a data company tracking the vaccine rollout, told The Times. Last month, the [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Page 27
  • Next

Trending Articles

  • As it happened: FTSE 100 relief rally runs out of steam as BP and Shell weigh; Oil hits three-month low

  • Rolls-Royce shares surge as SMR unit bags multi-billion pound Swedish nuclear contract

  • Rathbones to suspend thousands of client account inflows after FCA probe deals £530m blow

  • London Tech Week sums up everything wrong with UK tech

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

CityAM Canada — business, markets and opinion for Canadian readers.

Sections

  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities

Company

  • About
  • Contact

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 CityAM Canada. All rights reserved.
Terms · Privacy · Cookies